The Foundation Trust, which is accountable to its local communities for the services it provides, has just given official ‘notice of elections’ for its Council of Governors.
Governors, who often see the role as an opportunity to give back to their local hospitals, are elected from public, patient and staff constituencies.
Deputy Lead Governor, David Dean, said part of the role involves attending meetings where Governors learn about the Trust’s strategy, activities and response to issues. There are opportunities to challenge and question the Board of Directors.
Those with more time can join in with activities such as patient experience meetings, ward inspections and discussions to help shape the long-term strategy of the Trust, which runs Addenbrooke’s and the Rosie Maternity Hospitals.
Mr Dean, who was elected as a public governor in July 2017, said: “The foundation trust is accountable to its local communities for the services they provide and a key piece of this accountability is through the Governors who are elected to represent their collective views
“It is hugely rewarding to see close up the efforts and commitment of everyone in the Trust pushing to provide the kindest, safest and best possible care for patients. We all know there are huge challenges for our Trust – from population growth to nurse recruitment – but as a Governor I can play a part in ensuring we get the best that is possible for our community in these tough times.”
The Trust says anyone over 16, and from any walk of life can apply, highlighting that it wants to reflect the communities it serves and has a strong commitment to diversity and inclusion.
For more information about becoming a governor contact the Trust Membership Office on 01223 256256 or visit the Trust website. Completed nomination forms must be returned by noon on Wednesday, 28 March.
About Cambridge University Hospitals
Cambridge University Hospitals (CUH) is one of the largest and best known hospitals in the country, delivering high-quality patient care through Addenbrooke’s and the Rosie Hospitals. CUH is a leading national centre for specialist treatment for rare or complex conditions and a university teaching hospital with a worldwide reputation.
CUH is a key partner in Cambridge University Health Partners (CUHP), one of only six academic health science centres in the UK, and is at the heart of the development of the Cambridge Biomedical Campus (CBC), which brings together on one site world-class biomedical research, patient care and education. As part of the Campus development, Papworth Hospital is creating a bespoke, purpose-built hospital, and AstraZeneca is building a new global R&D centre and corporate headquarters. The Campus is one of the government’s 20 National Institute for Health Research (NIHR) comprehensive biomedical research centres.